miR-21-5p在早期不良生活事件诱发肠易激综合征中的作用及机制

doi:10.3969/j.issn.2095-378X.2025.03.002

外科研究与新技术（中英文） ›› 2025, Vol. 14 ›› Issue (3): 204-210.doi: 10.3969/j.issn.2095-378X.2025.03.002

miR-21-5p在早期不良生活事件诱发肠易激综合征中的作用及机制

张海芹¹, 韩波², 周璐¹, 褚以忞¹, 徐莹¹, 彭海霞¹

1.上海交通大学医学院附属同仁医院消化内镜中心,上海 200336;
2.上海交通大学医学院附属同仁医院普外科,上海 200336

收稿日期:2024-12-02 出版日期:2025-09-28 发布日期:2025-10-17
通讯作者: 彭海霞,电子邮箱：haixiapeng@163.com
作者简介:张海芹(1991—),女,硕士,主治医师,从事临床消化系疾病工作
基金资助:
上海市卫生健康委员会青年基金（20214Y0434）; 胃肠肿瘤的转化研究与创新疗法重点实验室研究基金（ZDSYS-2021-04）; 上海市第六人民医院医疗集团科研基金（ly202003）; 上海市同仁医院院级基金（2020TRYJ（JC）09）

Role and mechanism of miR-21-5p in early adverse life events inducing irritable bowel syndrome

ZHANG Haiqin¹, HAN Bo², ZHOU Lu¹, CHU Yimin¹, XU Ying¹, PENG Haixia¹

1. Digestive Endoscopy Center, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China;
2. Department of General Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China

Received:2024-12-02 Online:2025-09-28 Published:2025-10-17

摘要/Abstract

摘要： 目的探讨miR-21-5p在早期不良生活事件诱发肠易激综合征（IBS）内脏超敏中的作用及其机制。方法通过母婴分离方法制备早期不良生活事件诱发成年内脏超敏大鼠模型,利用微RNA（miRNA）芯片结合定量聚合酶链反应（qPCR）筛选大鼠背根神经节（DRG）神经元中差异表达miRNA,通过生物信息学分析结合荧光素酶报告基因检测实验寻找差异表达miRNA的下游靶标,采用细胞和动物实验相结合来验证差异表达miRNA通过下游靶标参与母婴分离诱发成年大鼠内脏超敏的过程。结果 miR-21-5p显著高表达于母婴分离所致成年内脏超敏大鼠DRG神经元中（P<0.05）。生物信息学分析、荧光素酶报告基因检测和细胞实验提示转化生长因子β诱导（TGFBI）基因是miR-21-5p的靶基因。在细胞水平,miR-21-5p模拟物干预后DRG神经元内TGFBI蛋白水平显著下降（P<0.05）,miR-21-5p抑制剂干预后DRG神经元内TGFBI蛋白水平显著升高（P<0.05）。在整体动物水平,miR-21-5p激动剂干预后大鼠内脏敏感性较对照组显著升高（P<0.05）,TGFBI蛋白水平显著下降（P<0.05）;miR-21-5p拮抗剂干预后大鼠内脏敏感性较对照组显著下降（P<0.05）,TGFBI蛋白水平显著升高（P<0.05）。结论大鼠DRG中miR-21-5p通过抑制TGFBI表达,促进母婴分离诱发的内脏超敏,从而参与早期不良生活事件诱发成年IBS。

关键词: 肠易激综合征, 内脏超敏, miR-21-5p, 转化生长因子β诱导蛋白, 早期不良生活事件

Abstract: Objective To investigate the role of miR-21-5p in early adverse life events （EALs）-induced visceral hypersensitivity of irritable bowel syndrome （IBS） and its mechanism. Methods A rat model of visceral hypersensitivity induced by EALs in adult rats was established by mother-infant separation. MicroRNA （miRNA） microarrays combined with quantitative polymerease chain reaction （qPCR） were used to screen for differential miRNAs in dorsal root ganglion （DRG） neurons, and bioinformatics analysis combined with luciferase reporter gene assay was performed to search for downstream targets of the differential miRNAs. Cellular and animal experiments were combined to verify if the differential miRNAs were involved in mother-infant separation-induced visceral hypersensitivity through the downstream targets. Results MiR-21-5p was significantly overexpressed in the DRG neurons of mother-infant separation-induced adult visceral hypersensitivity rats （P<0.05）. Bioinformatics analysis, luciferase reporter gene assay, and cellular experiments suggested that transforming growth factor beta induction （TGFBI） gene was a miR-21-5p target gene. At the cellular level, the TGFBI protein level in DRG neurons was significantly decreased after miR-21-5p mimic intervention （P<0.05）, and significantly increased after miR-21-5p inhibitor intervention （P<0.05）. At the animal level, the visceral sensitivity was significantly higher （P<0.05） and TGFBI protein level was significantly lower （P<0.05） in rats after miR-21-5p agonist intervention compared with the control group,and visceral sensitivity was significantly lower （P<0.05） and the TGFBI protein level was significantly higher （P<0.05） in rats after miR-21-5p antagonist intervention compared with the control group. Conclusion MiR-21-5p in rat DRG promotes mother-infant separation-induced visceral hypersensitivity by inhibiting TGFBI expression, and thus participates in the development of adult IBS induced by EALs.

Key words: Irritable bowel syndrome, Visceral hypersensitivity, MiR-21-5p, Transforming growth factor beta induction, Early adverse life events

中图分类号:

R574

张海芹, 韩波, 周璐, 褚以忞, 徐莹, 彭海霞. miR-21-5p在早期不良生活事件诱发肠易激综合征中的作用及机制[J]. 外科研究与新技术（中英文）, 2025, 14(3): 204-210.

ZHANG Haiqin, HAN Bo, ZHOU Lu, CHU Yimin, XU Ying, PENG Haixia. Role and mechanism of miR-21-5p in early adverse life events inducing irritable bowel syndrome[J]. Surgical Research and New Technique, 2025, 14(3): 204-210.

参考文献

[1] Cashman MD, Martin DK, Dhillon S, et al.Irritable bowel syndrome:a clinical review[J]. CurrRheumatol Rev,2016,12(1):13-26.
[2] Kanazawa M, Hongo M, Fukudo S.Visceral hypersensitivity in irritable bowel syndrome[J]. J Gastroenterol Hepatol,2011,26(3):119-121.
[3] Nguyen HT, Dalmasso G, Muller S, et al.Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy[J].Gastroenterology,2014,146(2):508-519.
[4] Kalla R, Ventham NT, Kennedy NA, et al.MicroRNAs:new players in IBD[J]. Gut,2015,64(3):504-517.
[5] Defrees DN, Bailey J.Irritable bowel syndrome:epidemiology,pathophysiology,diagnosis,and treatment[J]. Prim Care,2017,44(4):655-671.
[6] Chey WD, Kurlander J, Eswaran S.Irritable bowel syndrome:a clinical review[J]. JAMA,2015,313(9):949-958.
[7] Longstreth GF, Thompson WG, Chey WD, et al.Functional bowel disorders[J]. Gastroenterology,2006,130(5):1480-1491.
[8] 董智瑀,许树长. 脑源性神经营养因子介导精神应激诱发内脏高敏感的研究进展[J]. 外科研究与新技术,2017,6(3):209-211.
[9] Bradford K, Shih W, Videlock EJ, et al.Association between early adverse life events and irritable bowel syndrome[J]. Clin Gastroenterol Hepatol,2012,10(4):385-390.
[10] Farzaei MH, Bahramsoltani R, Abdollahi M, et al.The role of visceral hypersensitivity in irritable bowel syndrome:pharmacological targets and novel treatments[J]. J Neurogastroenterol Motil,2016,22(4):558-574.
[11] Bartel DP.MicroRNAs:target recognition and regulatory functions[J]. Cell,2009,136(2):215-233.
[12] Yu W, Zhu K, Wang Y, et al.Overexpression of miR-21-5p promotes proliferation and invasion of colon adenocarcinoma cells through targeting CHL1[J]. Mol Med,2018,24(1):36.
[13] Clancy C, Joyce MR, Kerin MJ.The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer[J].Cancer Biomark,2015,15(2):103-13.
[14] Cong M, Shen M, Wu X, et al.Improvement of sensory neuron growth and survival via negatively regulating PTEN by miR-21-5p-contained small extracellular vesicles from skin precursor-derived Schwann cells[J]. Stem Cell Res Ther,2021,12(1):80.
[15] Santos F, Cabreira V, Rocha S, et al.Blood biomarkers for the diagnosis of neurodegenerative dementia:a systematic review[J]. J Geriatr Psychiatry Neurol,2023,36(4):267-281.
[16] Zhang ZJ, Guo JS, Li SS, et al.TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG[J]. J Exp Med,2018,215(12):3019-3037.
[17] Wojtowicz K, Świerczewska M, Nowicki M, et al.The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines[J]. Adv Med Sci,2023,68(2):379-385.
[18] Chiavarina B, Costanza B, Ronca R, et al.Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.Theranostics[J]. 2021,11(4):1626-1640.
[19] Fico F,Santamaria-Martínez A.TGFBI modulates tumour hypoxia and promotes breast cancer metastasis[J].Mol Oncol,2020,14(12):3198-3210.
[20] Qiu Z, Ma X, Xie J, et al.miR-1307-5p regulates proliferation and apoptosis of chondrocytes in osteoarthritis by specifically inhibiting transforming growth factor beta-induced gene[J]. Am J Transl Res,2021,13(7):7756-7766.
[21] Hong Y, Li Z, Su Y, et al.The ceRNA mechanism of lncRNA MEG3/miR-21-5p/SPRY2 in cell proliferation and apoptosis in bladder cancer[J]. Crit Rev Eukaryot Gene Expr,2024;34(1):55-68.
[22] Yan L, Ma J, Wang Y, et al.miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells[J].ExpTher Med,2018,16(6):4655-4663.

miR-21-5p在早期不良生活事件诱发肠易激综合征中的作用及机制

Role and mechanism of miR-21-5p in early adverse life events inducing irritable bowel syndrome

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价